Oracle Health Sciences White Paper: Beyond SDV: Enabling Holistic, Strategic Risk-Based Monitoring

If you are having trouble viewing this email, please view it on our website

Oracle Health Sciences Whitepaper:
How Oracle Health Sciences “Monitoring Cloud” Enables Holistic, Strategic Risk-Based Monitoring

Oracle Health Sciences Webcast:
Optimize Efficiency and Manage Growing Case Volume and Complexity with Oracle Argus Enterprise Edition

Long discussed but rarely implemented, risk-based monitoring is coming into its own as an effective and pragmatic methodology to enhance patient safety while delivering significant efficiency benefits through reduced costs and better utilization of resources.

This new white paper from Oracle Health Sciences examines the current state of risk-based monitoring and builds on the extensive work done by TransCelerate BioPharma as well as regulatory authorities worldwide. It reviews the limitations of current eClinical technology to support the monitoring best practices called for, and why sponsors and CROs are shifting to comprehensive, real-time analytics – integrated with trial management, mobility, and data from any standards-based EDC system – as the technology backbone to effectively conduct a strategic risk-based monitoring program.

Click Here to View

Beyond SDV: Enabling Holistic, Strategic Risk-Based Monitoring

How Oracle Health Sciences Integrated Clinical R&D Cloud Platform Supports Risk-Based Monitoring Best Practices

Stay Connected

Oracle Corporation - Worldwide Headquarters, 500 Oracle Parkway, OPL - E-mail Services, Redwood Shores, CA 94065, United States

Your privacy is important to us. You can login to your account to update your e-mail subscriptions or you can opt-out of all Oracle Marketing e-mails at any time.

Pharmaceutical Executive is published by Advanstar Communications, 485 Rt 1 South, Iselin, NJ
This is an advertisement sent on behalf of this advertiser.